3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
cyclopia sequence
10
Lung Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Multiple Myeloma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sleepiness
1
Peripheral Nervous System Diseases
1
Parasomnias
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Diseases
1
Hypesthesia
1
Glioma
1
Fatigue
1
Exanthema
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Carcinoma
1
Anxiety Disorders
1
Anorexia
1
Acute Pain
1
Interventions
benralizumab
1
Triamcinolone Acetonide
1
Tetracycline
1
Sirolimus
1
Panitumumab
1
Minocycline
1
Irinotecan
1
IFL protocol
1
Hydrocortisone
1
Gels
1
Fulvestrant
1
Erlotinib Hydrochloride
1
Dapsone
1
Clindamycin
1
Anti-Bacterial Agents
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Exanthema
×
Minocycline
×
Clear all
NCT00473083
2017-04-04
LUTRAERL
British Columbia Cancer Agency
Phase 2
Completed
150 enrolled
13 charts